Treatment of multiple myeloma
US-2026027084-A1 · Jan 29, 2026 · US
This page is not indexed by search engines while we improve data quality.
Williams Rex patents
Williams Rex is listed as an inventor on 29 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Williams Rex |
| Total patents | 29 |
| First publication | Feb 16, 2023 |
| Latest publication | Jan 29, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Treatments with nirogacestat
US-2025025446-A1 · Jan 23, 2025 · US
Treatments with nirogacestat
US-12186305-B2 · Jan 7, 2025 · US
Treatments with nirogacestat
US-12138246-B2 · Nov 12, 2024 · US
Compositions and treatments with nirogacestat
US-2024316007-A1 · Sep 26, 2024 · US
Treatments with nirogacestat
US-2024245648-A1 · Jul 25, 2024 · US
Treatments with nirogacestat
US-12036207-B2 · Jul 16, 2024 · US
Treatments with nirogacestat
US-12011434-B2 · Jun 18, 2024 · US
Treatments with nirogacestat
US-12011435-B2 · Jun 18, 2024 · US
Treatments with nirogacestat
US-2024189282-A1 · Jun 13, 2024 · US
Recent patents
Latest publications not already listed above.
Improved treatment of ovarian cancer with nirogacestat
US-2024180874-A1 · Jun 6, 2024 · US
Treatments with nirogacestat
US-2024156784-A1 · May 16, 2024 · US
Treatments with nirogacestat
US-2024148695-A1 · May 9, 2024 · US
Treatments with nirogacestat
US-11957662-B2 · Apr 16, 2024 · US
Treatments with nirogacestat
US-11951096-B2 · Apr 9, 2024 · US
Treatments with nirogacestat
US-11938116-B2 · Mar 26, 2024 · US
Treatments with nirogacestat
US-2024091197-A1 · Mar 21, 2024 · US
Treatments with nirogacestat
US-11925619-B2 · Mar 12, 2024 · US
Treatments with nirogacestat
US-11925620-B1 · Mar 12, 2024 · US
Treatments with nirogacestat
US-2024066007-A1 · Feb 29, 2024 · US
Treatments with nirogacestat
US-2024058305-A1 · Feb 22, 2024 · US
Treatments with nirogacestat
US-2024050410-A1 · Feb 15, 2024 · US
Treatments with nirogacestat
US-2024050411-A1 · Feb 15, 2024 · US
Treatments with nirogacestat
US-2024033251-A1 · Feb 1, 2024 · US
Treatments with nirogacestat
US-11872211-B2 · Jan 16, 2024 · US
Treatments with nirogacestat
US-2023372300-A1 · Nov 23, 2023 · US
Treatments with nirogacestat
US-2023372301-A1 · Nov 23, 2023 · US
Solid state forms of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide and uses thereof
US-2023087828-A1 · Mar 23, 2023 · US
Methods of treating desmoid tumors with (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide
US-2023049311-A1 · Feb 16, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Springworks Therapeutics Inc | 29 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/417 | 27 |
| A61P35/00 | 24 |
| A61K9/0053 | 13 |
| A61K31/4164 | 13 |
| A61P19/00 | 12 |